Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review.
Tamás ZeleiNicholas D MendolaBaher ElezbawyBertalan NémethJonathan D CampbellPublished in: PharmacoEconomics - open (2021)
MCDA is a promising tool to include novel value criteria into the health technology assessment of therapies for rare diseases. To support the development of a transparent and justified evaluation process, scoring functions should be further investigated.